Newsbenzinga
Here’s How Much You Would Have Made Owning Corcept Therapeutics Stock In The Last 10 Years
· Published
Article summary
Corcept Therapeutics (NASDAQ:CORT) has outperformed the market over the past 10 years by 20.4% on an annualized basis producing an average annual return of 33.86%. Currently, Corcept Therapeutics has a market
An excerpt from the original article.
Comments —
Loading comments…